The Risk of Developing Long COVID in Patients with Inflammatory Bowel Diseases: Do Immunosuppressive Drugs Matter?

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

3 Downloads (Pure)

Original language	English
Pages (from-to)	1971-1972
Number of pages	4
Journal	Clinical Gastroenterology and Hepatology
Volume	21
Issue number	7
DOIs	https://doi.org/10.1016/j.cgh.2022.12.030
Publication status	Published - Jul-2023

Access to Document

@article{4477d3c729634260938ab432d34b2ff7,

title = "The Risk of Developing Long COVID in Patients with Inflammatory Bowel Diseases: Do Immunosuppressive Drugs Matter?",

author = "Bourgonje, {Arno R.} and Otten, {Antonius T.}",

year = "2023",

month = jul,

doi = "10.1016/j.cgh.2022.12.030",

language = "English",

volume = "21",

pages = "1971--1972",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",

publisher = "ELSEVIER SCIENCE INC",

number = "7",

}

TY - JOUR

T1 - The Risk of Developing Long COVID in Patients with Inflammatory Bowel Diseases

T2 - Do Immunosuppressive Drugs Matter?

AU - Bourgonje, Arno R.

AU - Otten, Antonius T.

PY - 2023/7

Y1 - 2023/7

U2 - 10.1016/j.cgh.2022.12.030

DO - 10.1016/j.cgh.2022.12.030

M3 - Comment/Letter to the editor

SN - 1542-3565

VL - 21

SP - 1971

EP - 1972

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

IS - 7

ER -